Clinically significant bleeding with immune checkpoint inhibitors: A retrospective cohort study

Eur J Cancer. 2020 Sep:137:285-287. doi: 10.1016/j.ejca.2020.07.005. Epub 2020 Aug 15.

Authors

Tariq Kewan¹, Fahrettin Covut², Ramsha Ahmed², Abdo Haddad³, Hamed Daw³

Affiliations

¹ Department of Internal Medicine, Cleveland Clinic Fairview Hospital, Cleveland, OH, USA. Electronic address: kewant@ccf.org.
² Department of Internal Medicine, Cleveland Clinic Fairview Hospital, Cleveland, OH, USA.
³ Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.

PMID: 32811686
DOI: 10.1016/j.ejca.2020.07.005

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Hemorrhage / chemically induced*
Humans
Immune Checkpoint Inhibitors / adverse effects*
Immunotherapy / methods*
Middle Aged
Retrospective Studies
Young Adult

Substances

Immune Checkpoint Inhibitors